215 related articles for article (PubMed ID: 3492500)
1. Human A673 cells secrete high molecular weight EGF-receptor binding growth factors that appear to be immunologically unrelated to EGF or TGF-alpha.
Stromberg K; Hudgins WR; Fryling CM; Hazarika P; Dedman JR; Pardue RL; Hargreaves WR; Orth DN
J Cell Biochem; 1986; 32(4):247-59. PubMed ID: 3492500
[TBL] [Abstract][Full Text] [Related]
2. Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine.
Stromberg K; Hudgins WR
Cancer Res; 1986 Nov; 46(11):6004-10. PubMed ID: 3019543
[TBL] [Abstract][Full Text] [Related]
3. Distinct high-performance liquid chromatography pattern of transforming growth factor activity in urine of cancer patients as compared with that of normal individuals.
Kimball ES; Bohn WH; Cockley KD; Warren TC; Sherwin SA
Cancer Res; 1984 Aug; 44(8):3613-9. PubMed ID: 6331653
[TBL] [Abstract][Full Text] [Related]
4. Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells.
Salomon DS; Perroteau I; Kidwell WR; Tam J; Derynck R
J Cell Physiol; 1987 Mar; 130(3):397-409. PubMed ID: 3494020
[TBL] [Abstract][Full Text] [Related]
5. Variant forms of rat epidermal growth factor present in the urine of nude rats bearing human tumors.
Hudgins WR; Orth DN; Stromberg K
Cancer Res; 1988 Mar; 48(6):1428-34. PubMed ID: 3257897
[TBL] [Abstract][Full Text] [Related]
6. Multiplicity of transforming growth factors in human malignant effusions.
Seo MK; Lynch KE; Podolsky DK
Cancer Res; 1988 Apr; 48(7):1792-7. PubMed ID: 2894891
[TBL] [Abstract][Full Text] [Related]
7. Characterization of transforming growth factors produced by the insulin-independent teratoma-derived cell line 1246-3A.
Yamada Y; Serrero G
J Cell Physiol; 1989 Aug; 140(2):254-63. PubMed ID: 2663884
[TBL] [Abstract][Full Text] [Related]
8. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
Ethier SP; Langton BC; Dilts CA
Mol Carcinog; 1996 Feb; 15(2):134-43. PubMed ID: 8599580
[TBL] [Abstract][Full Text] [Related]
9. Presence of growth factors in human pituitary.
Halper J; Parnell PG; Carter BJ; Ren P; Scheithauer BW
Lab Invest; 1992 May; 66(5):639-45. PubMed ID: 1573857
[TBL] [Abstract][Full Text] [Related]
10. [Growth factors produced by rat glioma cells: activities of transforming growth factors].
Kanno H; Shinonaga M; Kuwabara T; Umeda M
No To Shinkei; 1989 Sep; 41(9):905-9. PubMed ID: 2590559
[TBL] [Abstract][Full Text] [Related]
11. Human brain tumor-associated urinary high molecular weight transforming growth factor: a high molecular weight form of epidermal growth factor.
Stromberg K; Hudgins WR; Dorman LS; Henderson LE; Sowder RC; Sherrell BJ; Mount CD; Orth DN
Cancer Res; 1987 Feb; 47(4):1190-6. PubMed ID: 3026622
[TBL] [Abstract][Full Text] [Related]
12. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
Fernandez-Pol JA; Klos DJ; Grant GA
Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor alpha and beta expression in human colon cancer lines: implications for an autocrine model.
Coffey RJ; Goustin AS; Soderquist AM; Shipley GD; Wolfshohl J; Carpenter G; Moses HL
Cancer Res; 1987 Sep; 47(17):4590-4. PubMed ID: 2887281
[TBL] [Abstract][Full Text] [Related]
14. A Mr 43,000 epidermal growth factor-related protein purified from the urine of breast cancer patients.
Eckert K; Granetzny A; Fischer J; Nexø E; Grosse R
Cancer Res; 1990 Feb; 50(3):642-7. PubMed ID: 2297705
[TBL] [Abstract][Full Text] [Related]
15. Production of transforming growth factors by human colon cancer lines.
Coffey RJ; Shipley GD; Moses HL
Cancer Res; 1986 Mar; 46(3):1164-9. PubMed ID: 3002610
[TBL] [Abstract][Full Text] [Related]
16. Identification of a 15,000-molecular-weight form of immunoreactive transforming growth factor alpha in extracts of porcine pituitary.
Riss TL; Sirbasku DA
J Cell Physiol; 1989 Feb; 138(2):393-404. PubMed ID: 2918041
[TBL] [Abstract][Full Text] [Related]
17. Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor alpha.
Hofer DR; Sherwood ER; Bromberg WD; Mendelsohn J; Lee C; Kozlowski JM
Cancer Res; 1991 Jun; 51(11):2780-5. PubMed ID: 2032218
[TBL] [Abstract][Full Text] [Related]
18. Divergent effects of epidermal growth factor and transforming growth factors on a human endometrial carcinoma cell line.
Korc M; Haussler CA; Trookman NS
Cancer Res; 1987 Sep; 47(18):4909-14. PubMed ID: 3497713
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids coordinately disrupt a transforming growth factor alpha autocrine loop and suppress the growth of 13762NF-derived Con8 rat mammary adenocarcinoma cells.
Alexander DB; Goya L; Webster MK; Haraguchi T; Firestone GL
Cancer Res; 1993 Apr; 53(8):1808-15. PubMed ID: 8467499
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of epidermal growth factor, transforming growth factor-alpha, and vaccinia virus growth factor in the positive regulation of IFN-gamma production.
Abdullah NA; Torres BA; Basu M; Johnson HM
J Immunol; 1989 Jul; 143(1):113-7. PubMed ID: 2499624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
